Covetrus (CVET) Tops Q2 EPS by 32c

Covetrus (NASDAQ: CVET) reported Q2 EPS of $0.40, $0.32 better than the analyst estimate of $0.08. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $883.47 million.

2020 Financial Guidance:

Covetrus’ fiscal year 2020 financial guidance range is as follows, which assumes no significant additional supply chain disruption or economic impact related to COVID-19 in the second half of the year:

• Adjusted EBITDA, a non-GAAP financial metric, of $200 million to $210 million

For earnings history and earnings-related data on Covetrus (CVET) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c